Advancements in Atopic Dermatitis Treatment: Emerging Therapies and Expert Insights
At the ODAC 2025 conference, Dr. Shawn Kwatra, Professor and Chair of Dermatology at the University of Maryland School of Medicine and a leading figure in chronic inflammatory skin diseases, delivered a compelling presentation on atopic dermatitis (AD). Dr. Kwatra provided an overview of current AD treatment options, along with valuable insights into the latest advancements emerging in the field o …
At the ODAC 2025 conference, Dr. Shawn Kwatra, Professor and Chair of Dermatology at the University of Maryland School of Medicine and a leading figure in chronic inflammatory skin diseases, delivered a compelling presentation on atopic dermatitis (AD). Dr. Kwatra provided an overview of current AD treatment options, along with valuable insights into the latest advancements emerging in the field o … 
October's Journal of Drugs in Dermatology Editor's Picks offer an exciting look into cutting-edge research, with a special focus on atopic dermatitis and several related skin conditions. This month’s selections dive deep into groundbreaking studies, ranging from innovative treatments for acne and environmental skin aging to advancements in hyperhidrosis research using machine learnin … 
It’s an exciting time for new therapies in atopic dermatitis with several therapies recently approved or in late-stage development. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Baltimore dermatologist Dr. Shawn Kwatra, who outlined the new treatment options. From therapies that target IL-13 and IL-31 to JAK inhibitors, dermatology cl … 
Infection by which of the following organisms is most likely to be present in the patient’s condition?
A. Cutibacterium acnes
B. Herpes simplex virus
C. Poxvirus
D. Staphylococcus aureus
E. Streptococcus agalactiae
F. Streptococcus pyogenes
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl … 